Inhibition of human pancreatic cancer growth by the adenovirus-mediated introduction of a novel growth suppressing gene, tob, in vitro

Advances in Experimental Medicine and Biology

Volumn 451, Issue , 1998, Pages 91-96

  Yanagie, H ^a   Sumimoto, H ^a   Nonaka, Y ^a   Matsuda, S ^a   Hirose, I ^a   Hanada, S ^a   Sugiyama, H ^b   Mikamo, S ^a   Takeda, Y ^a   Yoshizaki, I ^a   Nakazawa, K ^a   Tani, K ^a   Yamamoto, T ^a   Asano, S ^a   Eriguchi, M ^a   Muto, T ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; GENE PRODUCT; MESSENGER RNA;

ADENOVIRUS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; PANCREAS CANCER; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0031724734     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-5357-1_15     Document Type: Article

References (5)

1. S. Matsuda, J. Kawamura, M. Ohsugi, M. Yoshida, M. Emi, Y. Nakamura, M. Onda, Y. Yoshida, A. Nishimura and T. Yamamoto, 1996; Tob, a novel protein that interacts with p185 erb B2 is associated with anti-proliferative activity, Oncogene, 12, 705-713.
2. F. Kanai, K.M. Lan, Y. Shiratori, T. Tanaka, M. Ohashi, T. Okudaira, Y. Yoshida, H. Wakimoto, H. Hamada, H. Nakabayashi, T. Tamaoki and M. Omata, 1997; In vivo gene therapy for α-fetoprotein-producing hepatocellular carcinoma by adenovirus-mediated transfer of cytosine deaminase gene, Cancer Res., 57, 461-465.
3. Y. Kanegae, G. Lee, Y. Sato, M. Tanaka, M. Nakai, T. Sasaki, S. Sugano and I. Saito, 1995; Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase, Nucleic Acids Res., 23, 3816-3821.
4. J.P. Rouault, R. Rimokh, C. Tessa, G. Paranhos, M. Ffrench, L. Duret, M. Garoccio, D. Germain, J. Samarut and J.P. Magaud, 1992; BTG-1, a member of a new family of antiproliferative genes, The EMBO Journal, 11, 1663-1670.
5. J.P. Rouault, N. Falette, F. Guehenneux, C. Guillot, R. Rimokh, Q. Wang, C. Berthet, CM. Lalle, P. Savatier, B. Pain, P. Shaw, R. Berger, J. Samarut, J.P. Magaud, M. Ozturk, C. Samarut and A. Puisieux, 1996; Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway, Nature Genet., 14, 482-486.